Risk of reinfection after seroconversion to SARS-CoV-2: A population-based propensity-score matched cohort study

Antonio Leidi, Flora Koegler, Roxane Dumont, Richard Dubos, María-Eugenia Zaballa, Giovanni Piumatti, Matteo Coen, Amandine Berner, Pauline Darbellay Farhoumand, Pauline Vetter, Nicolas Vuilleumier, Laurent Kaiser, Delphine Courvoisier, Andrew S Azman, Idris Guessous, Silvia Stringhini, SEROCoV-POP study group
doi: https://doi.org/10.1101/2021.03.19.21253889

Article usage

Article usage: March 2021 to January 2025

AbstractFullPdf
Mar 2021179048513
Apr 20218224695
May 202136443112
Jun 20211674156
Jul 20211066637
Aug 20211823021
Sep 2021883531
Oct 2021992632
Nov 2021913138
Dec 2021461617
Jan 202229178
Feb 202241315
Mar 202232310
Apr 202253314
May 202232118
Jun 2022102569
Jul 202225163
Aug 202232416
Sep 202235215
Oct 202239018
Nov 20221628
Dec 202225310
Jan 20232146
Feb 2023411012
Mar 20235219
Apr 202327216
May 202313211
Jun 20239979
Jul 20231438
Aug 202317109
Sep 20232077
Oct 20232034
Nov 2023241010
Dec 20233824
Jan 20247224
Feb 202429413
Mar 20244288
Apr 20242148
May 20241447
Jun 20241765
Jul 202420715
Aug 202416812
Sep 20242447
Oct 2024848
Nov 20241618
Dec 202417312
Jan 20251967
Back to top
Posted March 20, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Risk of reinfection after seroconversion to SARS-CoV-2: A population-based propensity-score matched cohort study
Antonio Leidi, Flora Koegler, Roxane Dumont, Richard Dubos, María-Eugenia Zaballa, Giovanni Piumatti, Matteo Coen, Amandine Berner, Pauline Darbellay Farhoumand, Pauline Vetter, Nicolas Vuilleumier, Laurent Kaiser, Delphine Courvoisier, Andrew S Azman, Idris Guessous, Silvia Stringhini, SEROCoV-POP study group
medRxiv 2021.03.19.21253889; doi: https://doi.org/10.1101/2021.03.19.21253889
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area